India's health sector permits 100% FDI under the automatic route. Critically evaluate whether sector-specific FDI caps are needed, drawing on recent parliamentary recommendations.

India allows 100% FDI in hospitals under the automatic route, credited with building world-class tertiary capacity. The Department-related Parliamentary Standing Committee on Health and Family Welfare, in its 176th Report on affordability and accessibility of healthcare (adopted 6 August 2026) [2], has reopened this settled policy — a review is merited, but a blunt cap is not the remedy.

The case for sector-specific caps

• The Committee warns of "aggressive corporatisation", with foreign capital enabling large chains to acquire cost-effective mid-sized hospitals, escalating prices across the ecosystem [1].
• Affordability gap: average hospitalisation costs roughly eight times more in private than government facilities, keeping out-of-pocket expenditure high [3].
• Ethical dimension: healthcare risks becoming a "purely capitalistic enterprise" rather than a public service [1].
• Federal mismatch: FDI policy is a Union subject while public health and hospitals are largely State List, so states bear the affordability fallout without controlling entry [1].

The case against caps

• Open FDI made India a cost-effective global medical destination; capping it in a capital-scarce sector could stall infrastructure in Tier-2/3 towns.
• The Committee itself seeks rationalisation, not prohibition, and expressly favours FDI in medical devices, consumables and rare-disease medicines [3].
• Ownership caps do not fix price opacity — the real driver. Hence the panel's own remedies: an institutional mechanism to cap treatment, diagnostic and routine-procedure costs, and rationalised room charges [1].
• Frequent tinkering with the automatic route weakens policy predictability for investors.

Sector-specific caps are therefore a second-best instrument; the sharper tools are conditional entry and pricing regulation. A calibrated framework — merger and acquisition scrutiny for hospital consolidation, a structured cross-subsidisation obligation tying FDI-backed facilities to domestic patients, and rigorous enforcement of the Clinical Establishments Act, 2010 alongside PM-JAY — can retain foreign capital while advancing Article 21's right to health and SDG-3's universal health coverage goal.